Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma

被引:153
作者
Gomez, Dhanwant [1 ]
Morris-Stiff, Gareth [1 ]
Toogood, Giles J. [1 ]
Lodge, J. Peter A. [1 ]
Prasad, K. Rajendra [1 ]
机构
[1] St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Hepatobiliary & Transplantat Unit, Leeds LS9 7TF, W Yorkshire, England
关键词
cholangiocarcinoma; intrahepatic; disease-free; survival; resection;
D O I
10.1002/jso.21001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: To analyse the results and prognostic factors affecting disease-free and overall survival following potentially curative resection for intrahepatic cholangiocarcinoma (IHCC). Methods: Patients undergoing resection for IHCC from January 1996 to December 2006 were included. Data analysed included demographics, clinical and histopathology data. Results: Twenty-seven patients were identified with a median age of 57 (32-84) years. The 1-, 3- and 5-year overall and disease-free survival rates were 74%, 16% and 16%, and 44%, 15% and 15%, respectively. On univariate analysis, age <65 years, female gender, neutrophil to lymphocyte ratio (NLR) >= 5, micro-vascular invasion and lymph node involvement were predictors of poorer overall survival. Multivariate analysis did not identify any independent predictors of overall survival. A NLR >= 5 was the only adverse predictor of disease-free survival. The median disease-free survival of patients with NLR >= 5 was 6 months compared to 18 months for those with NLR < 5. There was a significant association between patients with a NLR >= 5 and larger turnout size, satellite lesions, micro-vascular invasion and lymph node involvement. Conclusion: Long-term outcome following resection of IHCC is poor. A pre-operative NLR >= 5 was an adverse predictor of disease-free survival and was associated with an aggressive tumour biology profile.
引用
收藏
页码:513 / 518
页数:6
相关论文
共 50 条
[1]  
BEFLOCQ A, 1998, AM J PATHOL, V152, P83
[2]   A western surgical experience of peripheral cholangiocarcinoma [J].
Berdah, SV ;
Delpero, JR ;
Garcia, S ;
Hardwigsen, J ;
LeTreut, YP .
BRITISH JOURNAL OF SURGERY, 1996, 83 (11) :1517-1521
[3]   Hepatic resection and transplantation for peripheral cholangiocarcinoma [J].
Casavilla, FA ;
Marsh, JW ;
Iwatsuki, S ;
Todo, S ;
Lee, RG ;
Madariaga, JR ;
Pinna, A ;
Dvorchik, I ;
Fung, JJ ;
Starzl, TE .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1997, 185 (05) :429-436
[4]  
CHU K, 2005, WORLD J SURG, V21, P301
[5]   Intrahepatic cholangiocarcinoma [J].
Chu, KM ;
Lai, ECS ;
AlHadeedi, S ;
Arcilla, CE ;
Lo, CM ;
Liu, CL ;
Fan, ST ;
Wong, J .
WORLD JOURNAL OF SURGERY, 1997, 21 (03) :301-306
[6]  
COUINAUD C, 1954, PRESSE MED, V62, P709
[7]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[8]   Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention [J].
Duffy, BK ;
Gurm, HS ;
Rajagopal, V ;
Gupta, R ;
Ellis, SG ;
Bhatt, DL .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (07) :993-996
[9]   p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer [J].
Fondevila, C ;
Metges, JP ;
Fuster, J ;
Grau, JJ ;
Palacín, A ;
Castells, A ;
Volant, A ;
Pera, M .
BRITISH JOURNAL OF CANCER, 2004, 90 (01) :206-215
[10]   A prospective study of serum C-reactive protein and colorectal cancer risk in men [J].
Gunter, MJ ;
Stolzenberg-Solomon, R ;
Cross, AJ ;
Leitzmann, MF ;
Weinstein, S ;
Wood, RJ ;
Virtamo, J ;
Taylor, PR ;
Albanes, D ;
Sinha, R .
CANCER RESEARCH, 2006, 66 (04) :2483-2487